Tocotrienols activate diacylglycerol kinase a via 67 KDa laminin receptor
DOI:
https://doi.org/10.31989/ffs.v5i5.1638Abstract
Background: Diabetes is a significant social issue. Controlling diabetic complications such as nephropathy is crucial for the quality of life (QOL) of diabetic patients. The abnormal activation of protein kinase C (PKC) through increased diacylglycerol levels (DG) due to hyperglycemia is a common mechanism that causes diabetic complications. Diacylglycerol kinase (DGK) can attenuate PKC activity by converting DG to phosphatidic acid. Thus far, d-α-tocopherol (αToc) treatment has been shown to prevent early changes of diabetic renal dysfunctions by activating DGKα via the 67KDa laminin receptor.
Vitamin E is classified into tocopherols (Toc) and tocotrienols (T3) with four derivatives: α, β, γα, β, γ, and δ. We have found that all Tocs induced the translocation of DGKα. However, it remains unclear if T3s also induced translocation of DGKα.
Objective: The objective of the study was to investigate the relationship between tocotrienols (T3s) and induced translocation of DGKα, while exploring the mechanism underlying T3s-induced translocation of DGKα.
Results: Similarly to a-tocopherol, α-T3 binds to 67LR, resulting in the induction of a translocation of DGK. As well as α- T3, β, γ, δ, and α Tocs induced translocation of DGK.
Conclusion: αT3, like αToc, activates DGKα by binding to Leu58 and Trp176 in 67LR. It means 67LR may be important for the functions of T3s, especially the non-oxidant effects of T3s.
Keywords: catechins, diabetic nephropathy, diacylglycerol kinase, vitamin E
Downloads
Published
Issue
Section
License
Copyright (c) 2025 FFS/Functional Food Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.